Results 81 to 90 of about 76,738 (248)

Challenges in estimating the impact of pneumococcal conjugate vaccines through surveillance [PDF]

open access: yes, 2012
SCOPUS: re.jinfo:eu-repo/semantics ...
Hanquet, Germaine, Vergison, Anne
core   +1 more source

Proposal of a Vaccination Needs Index to Prioritise Municipal Interventions in Brazil

open access: yesTropical Medicine &International Health, EarlyView.
ABSTRACT Addressing population health needs requires integrating indicators expressed on non‐comparable scales, particularly for vaccination, a cornerstone of public health. Objective To propose and implement a Vaccination Needs Index based on national administrative data on tracer vaccines for children to support the prioritisation of Brazilian ...
Fredi Alexander Diaz‐Quijano   +4 more
wiley   +1 more source

A Trial of a 7-Valent Pneumococcal Conjugate Vaccine in HIV-Infected Adults. [PDF]

open access: yes, 2010
BACKGROUND: Streptococcus pneumoniae is a leading and serious coinfection in adults with human immunodeficiency virus (HIV) infection, particularly in Africa.
French, N   +9 more
core   +4 more sources

Epidemiological approaches to evaluate clinical unmasking of HPV‐associated cervical lesions in the HPV vaccination era

open access: yesInternational Journal of Cancer, Volume 158, Issue 4, Page 847-857, 15 February 2026.
Abstract HPV vaccination reduces the risk of developing HPV‐attributable cancers, including cervical cancer. However, an attenuation of HPV vaccine impact after the implementation of HPV vaccination may occur through clinical unmasking. Clinical unmasking is a distinct and complex phenomenon that arises in the absence of clinical interventions ...
Joseph E. Tota   +8 more
wiley   +1 more source

Pneumococcal Infection and Vaccination-Related Knowledge, Attitudes and Practices Among Saudi Residents

open access: yesPathogens
Background and aims: Pneumococcal infections, primarily caused by Streptococcus pneumoniae, pose significant global public health challenges, particularly in vulnerable populations. In Saudi Arabia, the introduction of pneumococcal vaccination has been a
Wed S. Althobaiti   +8 more
doaj   +1 more source

Emerging Challenges and Opportunities in Infectious Disease Epidemiology. [PDF]

open access: yes, 2019
Much of the intellectual tradition of modern epidemiology stems from efforts to understand and combat chronic diseases persisting through the 20th century epidemiologic transition of countries such as the United States and United Kingdom.
Lewnard, Joseph A, Reingold, Arthur L
core  

Impact of infection preventionists on Centers for Medicare and Medicaid quality measures in Maryland nursing homes. [PDF]

open access: yes, 2014
BackgroundHealth care-associated infections are the leading cause of morbidity and mortality in US nursing homes (NHs). The objective of the research is to assess the impact of Maryland NH infection preventionists (IPs) on NH quality measures.MethodsTwo ...
Castle, Nicholas G   +2 more
core   +1 more source

Economic Burden of Sickle Cell Disease: A Retrospective Study of Pediatric and Adult Individuals With Medicaid Coverage From 2016 to 2020

open access: yesAmerican Journal of Hematology, Volume 101, Issue 2, Page 269-280, February 2026.
ABSTRACT There is limited information regarding the contemporary real‐world clinical and financial burden of Medicaid enrollees with sickle cell disease (SCD) in the United States. Using the IBM MarketScan Medicaid database (7/2016–12/2020), individuals with ≥ 3 SCD diagnoses were matched 1:1 on age, gender, and race to individuals without SCD ...
Giovanna Tedesco Barcelos   +4 more
wiley   +1 more source

Preventive measures in infancy to reduce under-five mortality: a case-control study in The Gambia.

open access: yes, 2009
OBJECTIVE: To investigate the relationship between child mortality and common preventive interventions: vaccination, trained birthing attendants, tetanus toxoid during pregnancy, breastfeeding and vitamin A supplementation. METHODS: Case-control study in
Adegbola, Richard A   +8 more
core   +1 more source

Iptacopan for Immune Thrombocytopenia and Cold Agglutinin Disease: A Global Phase 2 Basket Clinical Trial

open access: yesAmerican Journal of Hematology, Volume 101, Issue 2, Page 242-254, February 2026.
ABSTRACT Iptacopan is a first‐in‐class, oral, selective inhibitor of complement factor B that has demonstrated positive efficacy across several complement‐driven diseases. Here we evaluate the efficacy and safety of iptacopan monotherapy in adult patients with primary immune thrombocytopenia (ITP) and primary cold agglutinin disease (CAD). We performed
Alexander Röth   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy